Taking Mounjaro Without a Gallbladder: What You Need to Decide

Why this question matters even after your gallbladder is gone

Most people who ask whether they can use Mounjaro without a gallbladder have already had surgery, often years earlier, and are surprised to find gallbladder-related risks still mentioned in the medicine's leaflet. The reason is that tirzepatide (like other GLP-1 medicines) influences how quickly food moves through your digestive system. Slower gastric emptying changes the rhythm of bile secretion, and even without a gallbladder, bile is still produced by your liver and drains directly into the small intestine through the bile duct. That pathway can still be affected.

The NHS tirzepatide medicines page notes gallbladder problems as a possible side effect, though an uncommon one. This is consistent with what's seen across the GLP-1 class. People who have already had their gallbladder removed are not automatically exempt from bile-duct related issues, so the risk profile is different, not zero. A prescriber who knows about your cholecystectomy can weigh this properly; it's one reason a structured clinical assessment matters more than a checklist.

If you're thinking about starting treatment and have questions about whether you can have Mounjaro with no gallbladder, that history should be disclosed clearly at consultation. Our clinical team reviews each patient's full medical background before any prescription is issued.

The specific gallbladder risks associated with GLP-1 medicines

Clinical trials for tirzepatide, including the SURMOUNT programme involving thousands of adults, identified gallbladder disorders (cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation)) as uncommon but recorded adverse events. The mechanism is thought to involve reduced gallbladder contractility during treatment: bile becomes more concentrated, and stones can form more readily. You can read a fuller account of the clinical findings on our Mounjaro and gallbladder page.

For someone who has already had their gallbladder removed, the formation of new gallstones in the gallbladder itself is obviously not possible. The risk that remains is related to the bile ducts, bile duct stones (choledocholithiasis) can develop independently of the gallbladder, and altered bile dynamics may contribute. This is not unique to tirzepatide; it applies across the GLP-1 class. It does not mean treatment is unsuitable, but it is a genuine factor in the clinical conversation rather than a box-ticking exercise. For a broader look at what Mounjaro can and can't be taken alongside, our Mounjaro side effects page covers the full profile.

When to get medical help, and what symptoms to watch for

This is the section that matters most. If you start Mounjaro without a gallbladder and notice any of the following, contact a doctor promptly rather than waiting for your next review: severe or persistent pain in the upper right side of your abdomen; pain that radiates through to your back; yellowing of the skin or whites of the eyes (jaundice); dark urine or pale stools; high fever alongside abdominal pain. These can indicate bile duct obstruction or other biliary complications that need urgent assessment.

Equally important: the MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known, if infrequent, risk with GLP-1 medicines. The warning sign is severe stomach pain, often persistent and radiating to the back, sometimes with vomiting. If you experience that pattern, seek urgent medical attention. You can report any suspected side effect through the MHRA's Yellow Card scheme, reporting matters because it helps regulators track real-world safety signals. A full rundown of gallbladder-related pain patterns on this treatment is on our gallbladder pain and Mounjaro page.

Making the decision: what a prescriber actually considers

If you're based in the UK and wondering whether you can take Mounjaro with no gallbladder, the answer is really a question about your individual risk profile, not a universal yes or no. A prescriber will typically want to know: how long ago the cholecystectomy was, whether it was uncomplicated, whether you have a history of bile duct issues, and how your digestion has been since. They'll also consider your reasons for seeking treatment, your BMI, and any other conditions you have. You can explore the broader treatment picture on our weight-loss treatments page.

Rapid weight loss of any kind (not just from medication) is associated with an increased risk of biliary complications, so the weight-loss journey itself carries some relevance to bile metabolism even without a functioning gallbladder. Tirzepatide's effect on appetite and caloric intake can produce meaningful weight change, particularly in the early months. That's not a reason to avoid it, but it is a reason to be monitored properly. For context on how Mounjaro works and what to expect, the Mounjaro overview page is a good starting point. If you'd like to discuss your specific history, our prescribers review suitability and side-effect considerations as part of every consultation, speak to our team to get started.